NCT03339115 - AHEAD: European Feasibility Study of the Cardiovalve Transfemoral Mitral Valve System | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 23, 2018

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2029

Conditions

Mitral RegurgitationMitral Valve Disease

Interventions

DEVICE

Cardiovalve Transfemoral Mitral Valve

The Cardiovalve Transfemoral Mitral Valve System is intended for use symptomatic patients with severe mitral regurgitation who are at elevated risk for surgical mitral valve repair or replacement and who are anatomically eligible for transfemoral mitral valve replacement with transseptal access to the left atrium.

Trial Locations (11)

20129

RECRUITING

San Raffaele Hospital, Milan

53127

RECRUITING

Universitätsklinikum Bonn, Bonn

54100

RECRUITING

Fondazione Toscana G. Monasterio-Ospedale del Cuore, Massa

56126

RECRUITING

A.O.U. Pisana, Pisa

Unknown

NOT_YET_RECRUITING

Herzzentrum der Uniklinik Köln, Cologne

RECRUITING

Studienzentrale der Medizinische Klinik II Universitäres Herzzentrum Lübeck, Lübeck

NOT_YET_RECRUITING

Universitaet_Mainz, Mainz

RECRUITING

Klinikum der Universität München LMU, München

RECRUITING

Hygea, Athens

RECRUITING

Maria Cecilia Hospital, Cotignola

RECRUITING

Policlinico San Donato, Milan